… in the formation of liver glycogen, as … liver is termed hepatic steatosis. Absence of both
significant alcohol consumption and other liver disease is the criterion for defining simple hepatic …

… hepatic steatosis is a phenotype that recognizes diverse and complex causes and a wide
spectrum of clinical … or without T2DM, supports the clinical relevance of such a mechanism [51]. …

… mechanisms underlying T2DM and NAFLD, the relevance of … of subgroups at specific risk
of disease progression. Also, the … , liver steatosis could be associated with hepatic insulin …

… hepatic steatosis progression through several mechanisms, … apoptosis, in a fatty liver than
in a healthy liver. In addition, a … importance of Tregs in NAFLD and NASH, providing clinical …

… summarise the studies relevant to the understanding of type 2 diabetes as a reversible clinical
state. … Because hepatic steatosis is now the most common cause of moderately raised ALT …

… type 2 diabetes mellitus and related atherosclerotic diseases. Although the precise mechanism
… both treating diabetes and preventing cardiovascular diseases. For this purpose, insulin-…

… (NASH) and drugs under development that target relevant pathogenetic pathways. However,
to date … mechanisms that link hepatic steatosis with insulin resistance and type 2 diabetes. …

… and T2DM is of paramount importance for the reduction of the … for hepatic steatosis and
non-alcoholic fatty liver disease in … 2E1 in non-alcoholic fatty liver disease: mechanisms and …

… pathways involved in diabetes pathogenesis are represented as … one mechanism would
be identified to study the mechanism in … using these clinically relevant parameters provides a …

… hyperglycemia and EGP in clinical trials, only TZDs decrease steatosis and peripheral insulin
… cellular mechanisms underlying the effects of metformin, the only biguanide in clinical use, …